Try our Advanced Search for more refined results
Ranbaxy
-
Order | Filed: March 18, 2024 | Entered: March 18, 2024 BURLINGTON DRUG CO., INC. et al v. PFIZER INC. et al
Anti-Trust | New Jersey
Order
TEXT ORDER: The Court is in receipt of the letter filed on 3/15/24 (Dkt. 1383 ) requesting that defendants' opposition brief docketed at (Dkt. 1368 ) be unsealed. The request is granted. The Clerk is directed to unseal (Dkt. 1368 ). So Ordered by Magistrate Judge J. Brendan Day on 3/18/2024. (cry)
-
Complaint | Filed: March 15, 2024 | Entered: March 15, 2024 In re Xyrem (Sodium Oxybate) Antitrust Litigation
Anti-Trust | California Northern
Amended Complaint
AMENDED COMPLAINT against Eurohealth (USA), Inc., Hikma Labs Inc., Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc., Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals PLC, Jazz Pharmaceuticals, Inc.. Filed by Blue Cross and Blue Shield of Florida, Inc., Health Options Inc.. (Weiler, Matthew) (Filed on 3/15/2024)
-
Order | Filed: March 15, 2024 | Entered: March 15, 2024 BURLINGTON DRUG CO., INC. et al v. PFIZER INC. et al
Anti-Trust | New Jersey
Order
ORDER Directing EPPs to file a letter by March 18, 2024. Response due by March 22, 2024. Reply due by March 25, 2024. Signed by Judge Peter G. Sheridan on 3/15/2024. (amv)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login